Priority Review For Tetraphase's Eravacycline A 'Key Positive,' Analyst Says
February 28, 2018 at 14:48 PM EST
Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) announced Tuesday that the U.S. Food and Drug Administration accepted a New Drug ...
